Prevalence of metabolic syndrome according to ATPIII and IDF criteria in the Iranian population

Koomesh

Volumn 14, Issue 1, 2012, Pages 65-75

  Ghorbani, Raheb ^a   Abtahi naeini, Bahareh ^b   Eskandarian, Rahimeh ^a   Rashidy Pour, Ali ^a   Khamseh, Mohammad Ebrahim ^c   Malek, Mojtaba ^c  

^a SEMNAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Iranian population; Metabolic syndrome; Prevalence

Indexed keywords

ADENOSINE TRIPHOSPHATE; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ADULT TREATMENT PANEL III; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE ORGANIZATION; HUMAN; INTERNATIONAL DIABETES FEDERATION; IRAN; MALE; METABOLIC SYNDROME X; PREVALENCE; READING; RISK FACTOR; SMOKING;

EID: 84922686004     PISSN: 16087046     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the national heart, lung, and blood institute/american heart association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.
2. Hanson RL, Imperatore G, Bennett PH, Knowler WC. Components of the "metabolic syndrome" and incidence of type 2 diabetes. Diabetes 2002; 51: 3120-3127.
3. Eckel RH. Metabolic syndrome. In: Fauci A, Braunwald E, editors. Harrison's principles of internal medicine. 17th ed. New York: Mc graw hill 2008; P: 1509-1514.
4. Fakhrzadeh H, Ghotbi S, Pour-Ebrahim R, Nouri M, Heshmat R, Shafaee A, et al. Evaluation of prevalence of the metabolic syndrome in inhabitants of Tehran university of medical sciences population lab. Iran J Diabetes Lipid Disord 2004; 3: 71-80. (Persian).
5. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement. Circulation 2005; 112: 2735-2752.
6. Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome: a new worldwide definition from the international diabetes federation consensus. Lancet 2005; 366: 1059-1062.
7. Ghorbani R, Askandarian R, Malek M, Rashidy-pour A. Prevalence of hypertension among the adult population of Semnan province. Iran J Med Educ 2009; 10: 495-503. (Persian).
8. Malek M, Ghorbani R, Rashidi Pour A, Eskandarian R. Serum lipids status and its disorders among 30-70 years old population in Semnan province. koomesh 2012; 13: 292-299. (Persian).
9. Rashidy-Pour A, Malek M, Eskandarian R, Ghorbani, R. Obesity in the Iranian population. Obes Rev 2009; 10: 2-6.
10. Malek M, Hadaegh F, Harati H, Azizi F. Prediction of cardiovascular disease by metabolic syndrome in individuals aged over 40 yrs according to the ATP III and IDF definition: Tehran lipid and glucose study. Iran J Med Educ 2006; 8: 249-257. (Persian).
11. Daneshoour MS, Mehrabi Y, Hedayati M, Azizi F, Houshmand M. A multivariate study of metabolic syndrome risk factors, using factor analysis: Tehran lipid and glucose study. Iran J Med Educ 2006; 8: 139-146. (Persian).
12. Harzallah F, Alberti H, Ben Khalifa F. The metabolic syndrome in an Arab population: a first look at the new international diabetes federation criteria. Diabet Med 2006; 23: 441-444.
13. Ford ES. Prevalence of the metabolic syndrome defined by the international diabetes federation among adults in the U.S. Diabetes Care 2005; 28: 2745-2749.
14. Hadaegh F, Zabetian A, Azizi F. Prevention of metabolic syndrome in Iranian adult pupulation, concordance between the IDF with the ATPIII and the WHO definition. Iran J Diabetes Lipid Disord 2007; 6: 367-375. (Persian).
15. Sharifi F, Mousavinasab SN, Saeini M, Dinmohammadi M. Prevalence of metabolic syndrome in an adult urban population of the west of Iran. Exp Diabetes Res 2009; 2009: 136501.
16. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-359.
17. Keller KB, Lemberg L. Obesity and the metabolic syndrome. Am J Crit Care 2003; 12: 167-170.
18. Santos AC, Lopes C, Barros H. Prevalence of metabolic syndrome in the city of Porto. Rev Port Cardiol 2004; 23: 45-52.
19. Abdul-Rahim HF, Husseini A, Bjertness E, Giacaman R, Gordon NH, Jervell J. The metabolic syndrome in the West Bank population: an urban-rural comparison. Diabetes Care 2001; 24: 275-279.
20. Kim MH, Kim MK, Choi BY, Shin YJ. Prevalence of the metabolic syndrome and its association with cardiovascular disease in Korea. J Korean Med Sci 2004; 19: 195-201.
21. Esposito K, Marfella R, Citotola M, Dipalo C, Giugliano F, Giugliano G, et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004; 292: 1440-1446.
22. Jalali R, Vashegdani M, Dabaghmanesh MH, Ranjbar Omrani GH. Prevalence of the metabolic syndrome among adult in a rural area. Int J Endocrinol Metab 2009; 11: 405-414. (Persian).
23. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi R. First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care 2009; 32: 1092-1097.
24. Kwaśniewska M, Pikala M, Kaczmarczyk-Chałas K, Piwońaska A, Tykarski A, et al. Smoking status, the menopausal transition, and metabolic syndrome in women. Menopause 2012; 19: 194-201.